NIFTY 50

Standout Brokerage Report: Macquarie initiates coverages on three pharma firms

Updated : October 07, 2020 10:20:15 IST

Macquarie has written an extensive 77-page report on the CRAMS (contract research and contract manufacturing) and API (active pharmaceutical ingredient ) opportunities for Indian companies.

It believes that CRAMS is a multi-decade opportunity for Indian companies and hence has initiated coverage on 3 pharmaceutical firms – Divi's Laboratories, Syngene, and Solara.

CNBC-TV18’s Nimesh Shah gets more details from the report in the special segment ‘Standout Brokerage Report’.

To watch other videos in this series, click the 'Standout Brokerage Report' tab below.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV

recommended for you